American Diabetes Association

2022 standards of medical care in diabetes released

U.S. Food and Drug Administration

First-in-class siRNA, Inclisiran, approved to lower cholesterol

Vifor Pharma

Phase 3b DIAMOND trial meets primary endpoint

The New England Journal of Medicine

Study indicates high-sodium, low-potassium levels associated with increased CV risk

U.S. Food and Drug Administration

COVID-19 vaccine booster use expanded to include 12- to 15-year-olds

U.S. Preventative Services Task Force

New recommendations on aspirin use for CVD prevention

VTE: A Discussion on Screening, Prevention, and Transition of Care

In this episode of the Cardiometabolic Beat, Geoffrey D. Barnes, MD, MSc, cardiologist and vascular medicine specialist at the University of Michigan Health System, shares his clinical perspectives on the prevention and management of venous thromboembolism (VTE).

If you'd like to hear more insights from Dr. Barnes, check out CMHC's upcoming Frontiers in Interventional Cardiology Masterclass - he is one of the esteemed faculty leading this groundbreaking virtual course, January 28-29, 2022.

Health Tech Wearables for Cardiovascular Health

The growing trend of remote health monitoring can retrieve vital physiological data and cardiovascular measures such as heart rate, rhythm, and blood pressure using various innovative wearable devices.

Three days of comprehensive clinical education in cardiometabolic health provide the latest data and expert perspectives in this growing discipline. Attendees of CMHC events bring new skills, strategies, and knowledge back to their patients, improving outcomes in cardiometabolic disease areas such as obesity, diabetes, cardiovascular disease and cardiorenal disease.